Author:
Mélard Aurélie,Garcia Laetitia G.,Das Debaditya,Rozenberg Raoul,Tulkens Paul M.,Van Bambeke Françoise,Lemaire Sandrine
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference61 articles.
1. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity;Biek;J Antimicrob Chemother,2010
2. In vitro antimicrobial activity of T-91825, a novel anti-MRSA cephalosporin, and in vivo anti-MRSA activity of its prodrug, TAK-599;Iizawa;J Infect Chemother,2004
3. Summary of ceftaroline activity against pathogens in the United States, 2010: Report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program;Flamm;Antimicrob Agents Chemother,2012
4. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model;Zhanel;J Antimicrob Chemother,2011
5. TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties;Ishikawa;Bioorg Med Chem,2003
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献